{"schema":"hottub-news/story/v1","story":"st_e63lcdrduw7atxdmztxa","title":"Biocon gets European Commission nod for breast cancer biosimilar","title_en":"Biocon gets European Commission nod for breast cancer biosimilar","outlets":8,"brief":null,"page":"https://hottub.news/stories/biocon-secures-usfda-approval-for-pebrilzo-its-fifth-cancer-biosimilar-e63lcdrduw","count":10,"items":[{"id":"n_6446wdyi63lgkxpcui6a","seq":12563463,"kind":"article","title":"Biocon gets European Commission nod for breast cancer biosimilar","url":"https://www.thehindubusinessline.com/companies/biocon-gets-european-commission-nod-for-breast-cancer-biosimilar/article71716875.ece","published":"2026-11-18T15:34:00Z","seen":"2026-11-18T17:36:07Z","lang":"en","country":"IN","source":{"id":"thehindubusinessline.com","name":"thehindubusinessline.com","domain":"thehindubusinessline.com","outlet":{"wikidata":"Q279739","name":"Business Line","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"mentions":3,"story":"st_e63lcdrduw7atxdmztxa","category":"economy-business","category_p":0.3499999940395355,"category2":"science-technology","sentiment":"positive","tone":0.25999999046325684,"political":0.2199999988079071},{"id":"n_i4uegiuespvyh7ojrcfa","seq":12343873,"kind":"article","title":"Biocon gets European Commission nod for breast cancer biosimilar Pebrilzo","url":"https://www.dailyexcelsior.com/biocon-gets-european-commission-nod-for-breast-cancer-biosimilar-pebrilzo","published":"2026-11-18T06:23:17Z","seen":"2026-11-18T06:23:17Z","lang":"en","country":"IN","source":{"id":"dailyexcelsior.com","name":"dailyexcelsior.com","domain":"dailyexcelsior.com","outlet":{"wikidata":"Q5209247","name":"Daily Excelsior","type":"newspaper","country":"IN","designations":["newspaper","periodical"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_e63lcdrduw7atxdmztxa","category":"economy-business","category_p":0.41999998688697815,"category2":"health","sentiment":"positive","tone":0.4099999964237213,"political":0.25},{"id":"n_unicwofbrv2sgeevgdbq","seq":12323980,"kind":"article","title":"Biocon gets US FDA approval for Pebrilzo™ Injection, biosimilar to Perjeta®, expanding oncology portfolio","url":"https://www.biospectrumindia.com/news/104/28835/biocon-gets-us-fda-approval-for-pebrilzo-injection-biosimilar-to-perjeta-expanding-oncology-portfolio.html","published":"2026-11-18T05:07:00Z","seen":"2026-11-18T05:07:00Z","lang":"en","source":{"id":"biospectrumindia.com","name":"biospectrumindia.com","domain":"biospectrumindia.com"},"via":"gdelt-gkg-english","topics":["health","economy"],"entities":[{"id":"Q487694","name":"Biocon","type":"org"},{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q29006332","name":"Perjeta","type":"other"}],"story":"st_e63lcdrduw7atxdmztxa","category":"health","category_p":0.3799999952316284,"category2":"economy-business","sentiment":"positive","tone":0.4399999976158142,"political":0.17000000178813934},{"id":"n_olz4ak62absi4o47xuba","seq":12324579,"kind":"article","title":"Biocon gets US FDA approval for Pebrilzo™ Injection, biosimilar to Perjeta®, expanding oncology portfolio","url":"https://www.biospectrumindia.com/news/16/28835/biocon-gets-us-fda-approval-for-pebrilzo-injection-biosimilar-to-perjeta-expanding-oncology-portfolio.html","published":"2026-11-18T05:07:00Z","seen":"2026-11-18T05:07:00Z","lang":"en","source":{"id":"biospectrumindia.com","name":"biospectrumindia.com","domain":"biospectrumindia.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_e63lcdrduw7atxdmztxa","category":"health","category_p":0.3799999952316284,"category2":"economy-business","sentiment":"positive","tone":0.4399999976158142,"political":0.17000000178813934},{"id":"n_rqgyjqp75dtgojwhvwea","seq":12321536,"kind":"article","title":"Biocon gets European Commission nod for breast cancer biosimilar Pebrilzo","url":"https://www.livemint.com/focus/biocon-gets-european-commission-nod-for-breast-cancer-biosimilar-pebrilzo-11794976488365.html","published":"2026-11-18T04:53:44Z","seen":"2026-11-18T04:53:44Z","lang":"en","country":"IN","source":{"id":"livemint.com","name":"livemint.com","domain":"livemint.com","outlet":{"wikidata":"Q2271133","name":"Mint","type":"newspaper","country":"IN","designations":["business periodical","newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_e63lcdrduw7atxdmztxa","category":"economy-business","category_p":0.41999998688697815,"category2":"health","sentiment":"positive","tone":0.41999998688697815,"political":0.25},{"id":"n_xyhsmz6ey4zycz4wxuza","seq":11914142,"kind":"article","title":"Biocon gets US FDA approval for breast cancer drug Pebrilzo, plans US launch in 2028","url":"https://www.ibtimes.co.in/biocon-gets-us-fda-approval-breast-cancer-drug-pebrilzo-plans-us-launch-2028-908416","published":"2026-11-17T03:07:00Z","seen":"2026-11-17T07:05:04Z","lang":"en","country":"IN","source":{"id":"ibtimes.co.in","name":"ibtimes.co.in","domain":"ibtimes.co.in"},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Abhishek Trivedi"],"story":"st_e63lcdrduw7atxdmztxa","category":"economy-business","category_p":0.4099999964237213,"category2":"health","sentiment":"positive","tone":0.4000000059604645,"political":0.23999999463558197},{"id":"n_njb2657sxzyi4tl7zhea","seq":11623815,"kind":"article","title":"Biocon Gets US FDA Approval For Pebrilzo Breast Cancer Drug, Plans US Launch In 2028","url":"https://www.freepressjournal.in/business/biocon-gets-us-fda-approval-for-pebrilzo-breast-cancer-drug-plans-us-launch-in-2028","published":"2026-11-16T13:04:00Z","seen":"2026-11-16T14:00:36Z","lang":"en","country":"IN","source":{"id":"freepressjournal.in","name":"freepressjournal.in","domain":"freepressjournal.in","outlet":{"wikidata":"Q7735208","name":"The Free Press Journal","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["health","economy"],"story":"st_e63lcdrduw7atxdmztxa","category":"health","category_p":0.47999998927116394,"category2":"economy-business","sentiment":"positive","tone":0.5,"political":0.18000000715255737},{"id":"n_gzyy7slwj73dd3bikgiq","seq":11588744,"kind":"article","title":"Biocon gets US FDA approval for Pebrilzo™ Injection, biosimilar to Perjeta®, expanding oncology portfolio","url":"https://www.biospectrumindia.com/news/95/28835/biocon-gets-us-fda-approval-for-pebrilzo-injection-biosimilar-to-perjeta-expanding-oncology-portfolio.html","published":"2026-11-16T11:30:00Z","seen":"2026-11-16T12:13:19Z","lang":"en","source":{"id":"biospectrumindia.com","name":"biospectrumindia.com","domain":"biospectrumindia.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_e63lcdrduw7atxdmztxa","category":"health","category_p":0.3799999952316284,"category2":"economy-business","sentiment":"positive","tone":0.4399999976158142,"political":0.17000000178813934},{"id":"n_7rbsb6aetawzsieyj3vq","seq":11536235,"kind":"article","title":"Biocon gets USFDA nod for breast cancer biosimilar Pebrilzo","url":"https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-receives-usfda-approval-for-breast-cancer-biosimilar-pebrilzo-expanding-access-to-affordable-treatment/articleshow/135878009.cms","published":"2026-11-16T08:45:00Z","seen":"2026-11-16T09:32:36Z","lang":"en","country":"IN","source":{"id":"indiatimes.com","name":"indiatimes.com","domain":"indiatimes.com","outlet":{"wikidata":"Q113974698","name":"Indiatimes","type":"other","country":"IN","designations":["news media"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_e63lcdrduw7atxdmztxa","category":"economy-business","category_p":0.36000001430511475,"category2":"health","sentiment":"positive","tone":0.6499999761581421,"political":0.20000000298023224},{"id":"n_e63lcdrduw7atxdmztxa","seq":11472024,"kind":"article","title":"Biocon secures USFDA approval for Pebrilzo, its fifth cancer biosimilar","url":"https://www.business-standard.com/companies/news/biocon-secures-us-fda-approval-for-pebrilzo-its-fifth-cancer-biosimilar-126111600687_1.html","published":"2026-11-16T05:11:42Z","seen":"2026-11-16T05:11:42Z","lang":"en","country":"IN","source":{"id":"business-standard.com","name":"business-standard.com","domain":"business-standard.com","outlet":{"wikidata":"Q2307816","name":"Business Standard","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["health","economy"],"authors":["Business Standard"],"story":"st_e63lcdrduw7atxdmztxa","category":"health","category_p":0.25999999046325684,"category2":"science-technology","sentiment":"positive","tone":0.30000001192092896,"political":0.1599999964237213}]}